Laura Estera Tilea

LauraEstera Tilea

Especialidad:
Oncología Radioterápica
Especialidades:
  • Radiooncologia
Hospital / Centro:
  • Centro Médico Teknon
Información general
Experiencia

01/03/2021 – CURRENT – Barcelona, Spain
RADIATION ONCOLOGIST – CENTRO MÉDICO TEKNON
Working with the professional team at the Radiation Oncology Department. Treating patients with cancer (breast cancer, lung cancer, head and neck cancer, palliative care, etc.). Head of Department Jose Ignacio Toscas Vigara Ph.D.

15/06/2020 – 28/02/2021 – Barcelona, Spain
RADIATION ONCOLOGIST – HOSPITAL SANTA CREU I SANT PAU
Working with the professional team at the Radiation Oncology Department. Treating patients with urological cancer. Head of Department Gemma Sancho Pardo M.D., Ph.D.

01/12/2019 – 31/01/2020 – Leuven, Belgium
TRAINING IN STEREOTACTIC RT / OVERVIEW OF PROTON THERAPY – UNIVERSITAIR ZIEKENHUIS (UZ)
Acquisition of experience in:
- Lung SBRT, Brain FSRT/SRS, Bone SBRT.
- Overview of Proton Therapy (in the process of implementation).

01/10/2019 – 30/11/2019 – Oviedo, Spain
TRAINING IN BRACHYTHERAPY – HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS (HUCA)
Acquisition of experience in:
- LDR in Prostate cancer.
- HDR in Gynecological cancer, Prostate cancer and Keloids.

27/05/2016 – 26/05/2020 – Barcelona, Spain
RESIDENT TRAINING DOCTOR AT THE DEPARTMENT OF RADIATION ONCOLOGY – HOSPITAL SANTA CREU I SANT PAU
Acquisition of experience in:
- Patient care: External consultations, Hospitalization rooms.
- Treatment planning: 3D-CT Scan Simulation, 4D-CT Scan Simulation, PET-CT Scan Simulation, Image Registration (with other CT or MRi).
- Treatment techniques: 3D-RT, IGRT, IMRT, VMAT, SBRT, SFRT, Breath control (Gating, Breath-hold, Free- breathing), TBI, Low voltage surface radiotherapy (Therapax), LDR Brachytherapy.

Pathologies: breast cancer, gynecological cancer, head and neck cancer, sarcoma, prostate cancer, bladder cancer, digestive cancer, central nervous system cancer, lung cancer, hematological cancer, skin cancer.

Titulación

01/09/2009 – 31/05/2015 – Barcelona, Spain
DEGREE IN MEDICINE – Universitat de Barcelona - Facultat de Medicina (Campus Clínic)

Member of:
- SEOR (Sociedad Española de Oncología Radioterápica)
- ESTRO (European Society for Radiotherapy and Oncology)

Successfully realized:
-II Máster Internacional en Oncología Clínica (SEOR/EEOR 2016-2018)
-Training for supervisors of radioactive installations, field of application Radiotherapy (11-22 June 2018)

Publicaciones

Poster at ESTRO Congress (Madrid/Spain - 2021): Multifraction stereotactic radiotherapy for brain metastases: initial experience. S. Heylen, M. Lambrecht, G. Defraene, B. Vanstraelen, A. Nulens, L. Estera Tilea, J. Daisne, P. Berkovic.

N. Farré , J. Belda-Sanchis , M. Guarino , Laura Tilea , J. V. Rojas Cordero , E. Martínez-Téllez. The current role of surgery and SBRT in early stage of small cell lung cancer. J Clin Transl Res. 2021 Feb 17;7(1):34-48.

Poster ar SEOR XX Congress (Santiago de Compostela/Spain - 2019): MR-guided dose-intensified salvage radiotherapy after radical prostatectomy. Acosta E., Prado G, Soto A., Tilea L., Artola N., Farré N. Balart J., Majercakova K., Craven-Bartle J.

Poster ar SEOR XX Congress (Santiago de Compostela/Spain - 2019): Malignant spinal cord compression / simultaneous multidisciplinary management from the suspicion. Soto A., Acosta E., Sancho G., Tilea L., Vila A., Farré N., Majercakova K., Asencio C., Velazquez JJ., Calvo N., Craven-Bartle J.

Poster ar SEOR XX Congress (Santiago de Compostela/Spain - 2019): Reirradiation of head and neck cancer, a single center experience. Tilea L., Soto A., Acosta E., Farré N., Craven-Bartle J., León X., López M., García J., López-Pousa A., Majercakova K.

Poster at ESTRO 38 Congress (Milan/Italy - 2019): Feasibility of postprostatectomy dose intensified salvage radiotherapy by reduction of V70 and mean bladder dose. G. Sancho Pardo, E. Acosta, L. Tilea, A. Soto, N. Artola, N. Farré, J. Balart, G. Gómez de Segura, J. Craven-Bartle.

Poster at ESMO 2018 Congress (Munich/Germany - 2018): Impaired survival in resected glioblastoma multiforme patients treated with early chemoradiation. L.P. del Carpio, P. Gomila, S.D. Camacho, S. Moron, M. Riudavets, C. Molto, A. Bujosa, M. Borrell, R. Teres, B. Martin, P. Gallardo, E. Acosta, L. Tilea, A. Soto, C. De Quintana, J. Craven-Bartle, A. Gallardo, B. Gomez, S. Bonilla, O. Gallego.

Oral communication at IX revision of WCLC Toronto 2018 (Valencia/Spain - 2018): Multimodal treatment in pathologically confirmed single-station resectable IIIA-N2 non-small cell lung cáncer: a single center experience. L. Tilea.

Poster at IASLC 19th World Conference on Lung Cancer (Toronto/Canada -2018): Multimodal treatment in pathologically confirmed single-station resectable IIIA-N2 non-small cell lung cáncer: a single center experience. Tilea L., Acosta E., Majem M., Sullivan I., Barba A., Martínez E., Trujillo J.C., Belda J., Gómez De Segura G., Craven‐Bartle J., Giménez A., Camacho V., Fernández A., Torrego A., Pajares V., Farré N.

Poster at ESTRO 37 Congress (Barcelona/Spain - 2018): Postprostatectomy dose intensified salvage radiotherapy is associated with grade 3 late haematuria. G. Sancho Pardo, E. Acosta, L. Tilea, D. Hernández, N. Farré, J. Balart, N. Jornet, G. Gómez de Segura, J. Craven-Bartle.

Oral communication at XXVI GOCO Congress (Barcelona/Spain - 2018): Radiotherapy and Inmunotherapy in Cancer. Resume of XXV GOCO Congress (Montpellier) 2017.L. Tilea.